IMMUNOHISTOCHEMISTRY BCL-6 Test
At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY BCL-6 Test to detect the expression of the BCL-6 protein in tissue samples. This test is commonly used in the diagnosis and classification of various types of B-cell lymphomas.
Test Details
The BCL-6 test is an immunohistochemistry (IHC) test that involves staining tissue sections with specific antibodies that bind to the BCL-6 protein. This allows for the visualization of BCL-6 expression within the tissue sample. The staining intensity and distribution pattern of BCL-6 can provide valuable information about the presence and localization of B-cell lymphomas.
Test Components and Cost
The cost of the IMMUNOHISTOCHEMISTRY BCL-6 Test is AED 440.0. The test includes the following components:
- Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
- Report Delivery: Sample – Daily by 6 pm; Report Block – 5 days; Tissue Biopsy – 5 days; Tissue large complex – 7 days
- Method: Immunohistochemistry
- Test Type: Cancer
- Doctor: Oncologist, Pathologist
- Test Department: Pre Test Information – Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Significance of the Test
The BCL-6 test plays a crucial role in the diagnosis and classification of B-cell lymphomas. It helps differentiate between different subtypes of lymphomas, such as follicular lymphoma, diffuse large B-cell lymphoma, and Burkitt lymphoma. The test results, along with other clinical and pathological findings, can guide treatment decisions and determine the appropriate treatment approach for patients with B-cell lymphomas.
Conclusion
The IMMUNOHISTOCHEMISTRY BCL-6 Test offered by DNA Labs UAE is a valuable tool in the diagnosis and classification of B-cell lymphomas. With its ability to detect the expression of the BCL-6 protein in tissue samples, this test provides important information about the presence and localization of B-cell lymphomas. By accurately identifying different subtypes of lymphomas, the test results can guide treatment decisions and improve patient outcomes.
| Test Name | IMMUNOHISTOCHEMISTRY BCL-6 Test |
|---|---|
| Components | |
| Price | 440.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block : 5 days Tissue Biopsy : 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details |
The BCL-6 test is an immunohistochemistry (IHC) test used to detect the expression of the BCL-6 protein in tissue samples. BCL-6 is a transcription factor that plays a role in the regulation of B-cell development and function. The IHC technique involves staining tissue sections with specific antibodies that bind to the BCL-6 protein. This allows for the visualization of BCL-6 expression within the tissue sample. The staining intensity and distribution pattern of BCL-6 can provide valuable information about the presence and localization of B-cell lymphomas. The BCL-6 test is commonly used in the diagnosis and classification of various types of B-cell lymphomas, including follicular lymphoma, diffuse large B-cell lymphoma, and Burkitt lymphoma. It can help differentiate between different subtypes of lymphomas and guide treatment decisions. The results of the BCL-6 test are typically reported as positive or negative, indicating the presence or absence of BCL-6 expression in the tissue sample. The test results, along with other clinical and pathological findings, can help in determining the appropriate treatment approach for patients with B-cell lymphomas. |
